OS according to disease status and donor type. OS rates were significantly superior among patients transplanted in CR1. There was no significant difference between related and unrelated allo-SCTs (related vs unrelated: 65% vs 62% in CR1, P = .19; 44% vs 38% in subsequent CR, P = .66; and 17% vs 16% in nonremission, P = .59; respectively).